Last updated 2026-08-24
- Raised $10M Seed round led by We Ventures, Aug 2022
- Raised $10M Secondary, Jul 2012
Total raised
$20.0M
Stage
—
Founded
2007
Headcount
—
HQ
Orange, United States
Sector
MedTech
Website ↗Registrar ID: 512802083 (Kaylight Ltd.)
About
MyCells® is a revolutionary method that utilizes a patient's own blood to produce "Platelet Rich Plasma" (PRP), which is enriched with platelets, stem cells, and growth factors. When reintroduced into the body via injection, these substances accelerate the normal healing process by stimulating new collagen formation, leading to long-lasting tissue rejuvenation without side effects. PRP has been widely used in plastic surgery, orthopedics, dentistry, and for soft tissue implants and wound healing.
Funding history · 2 rounds · $20.0M total
2 events/rounds · $20.0M Total Funding: $20.0M in Private Equity
Aug 2022
★ We Ventures★ Spring Camp★ Stone Bridge★ Hyundai Motor Company★ Korea Development Bank★ Industrial Bank of Korea
Jul 2012
Offices
Orange, United States · HQ / main office
Q&A
- What is Kaylight Ltd. (MyCells)'s primary business?
- Kaylight Ltd. (MyCells) develops a skin regenerating system that uses the patient's own blood to produce Platelet Rich Plasma (PRP). This PRP is then reinjected to accelerate healing, stimulate collagen, and promote tissue rejuvenation.
- When was Kaylight Ltd. (MyCells) founded?
- Kaylight Ltd. (MyCells) was founded in 2007.
- What is the total amount of funding raised by Kaylight Ltd. (MyCells) to date?
- Kaylight Ltd. (MyCells) has raised a total of $23,000,000 in funding.
- When did Kaylight Ltd. (MyCells) receive its most recent funding?
- In August 2022, Kaylight Ltd. (MyCells) received a Seed funding round of $10,000,000.
- Which investors participated in Kaylight Ltd. (MyCells)'s August 2022 Seed round?
- The Seed funding round in August 2022 included investments from We Ventures.
- What was Kaylight Ltd. (MyCells)'s first recorded funding round?
- Kaylight Ltd. (MyCells) secured a Pre-Seed funding round of $10,000,000 in July 2012.
- What is the primary sector of Kaylight Ltd. (MyCells)?
- Kaylight Ltd. (MyCells)'s primary sector is Biotechnology.
- What is the core technology behind Kaylight Ltd. (MyCells)'s product?
- The core technology of Kaylight Ltd. (MyCells) is Platelet-Rich Plasma (PRP) preparation.
Team · 1
Tova Englard
Founder · CEO & Co-Founder
Sectors & technology
Primary sector
MedTech
Technologies
Target customers
Business model
B2C
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | my-cells.net |
|---|
Identifiers & details
| Legal name | Kaylight Ltd. |
|---|---|
| Founded | 2007 |
Radar intelligence
Web history (Wayback)
| Domain | my-cells.net |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 512802083 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 1999-07-07 |
| Purpose | לעסוק בסוגי עיסוק שפורטו בתקנון |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2024 |
| Active charges / liens | 0 |
| Registry events | 0 |
| Registered address | נחל שורק 18 רמת השרון |